The cardio-renal-metabolic space and obesity as a chronic disease, with Ramy Younes

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Ramy Younes, corporate vice president, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.

The conversation explores the crisis beyond obesity that many clinicians and health systems are now grappling with: that obesity can’t be treated as a short-term, weight-loss lifestyle issue. Rather, it needs to be managed as a complex, chronic, multi-organ disease.

Younes discusses how liver disease is often missed in cardiometabolic risk and is referred to as the ‘liver blind spot’, as well as what integrated pathways can do to improve outcomes and ease system pressure.

You can listen to episode 260 to go here of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.